title: Oncology drugs enter the US market faster than in Europe but cost more.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D057186:Comparative Effectiveness Research; D017047:Cost Sharing; D017277:Drug Approval; D016527:Drug Costs; D005060:Europe; D006297:Health Services Accessibility; D009369:Neoplasms / Q000188:drug therapy; D017063:Outcome Assessment, Health Care; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents